BAY 1135626 is used to synthesize BAY 1129980, and use to anti-tumor research. BAY 1129980 is a Auristatin-based anti-C4.4A (LYPD3) antibody-agent conjugate (ADC), is used to non-small cell lung cancer (NSCLC) research[1].
Molecular Weight:
1063.33
Purity:
99.19
CAS Number:
[1404071-37-9]
Formula:
C55H86N10O11
Target:
Drug-Linker Conjugates for ADC
Application Notes:
MCE Product type: ADC Related
* VAT and and shipping costs not included. Errors and price changes excepted